跳至主要内容
临床试验/ACTRN12619000292178
ACTRN12619000292178招募中未知

High-flow nasal cannula versus low-flow nasal cannula oxygenation in lung transplant patients undergoing diagnostic transbronchial biopsy: A randomised controlled trial

Dr Charles Cartwright0 个研究点目标入组 80 人开始时间: 2019年2月26日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Aged >=18 years old
  • Lung transplant patients
  • Undergoing transbronchial biopsy
  • English speaking and able to provide informed consent

排除标准

  • Aged <18 years old
  • Non-lung transplant patients
  • Participants not having transbronchial biopsies conducted
  • Non-English speaking and unable to provide informed consent
  • Pre-procedure: respiratory failure/cardiovascular failure/recent pneumothorax (<2 weeks)
  • Chest tube in-situ
  • Reduced level of consciousness
  • Pregnant women
  • Unable to have the procedure carried out with a propofol infusion
  • Significant aspiration risk (e.g. gastroparesis/severe GORD) or unable to have the procedure done without endotracheal intubation
  • Unsuitable for nasal cannulae – recent nasal surgery/epistaxis, significant nasal or sinus issue, marked septal deviation, basal skull fracture
  • Clinical need for an LMA/intubation

研究者

发起方
Dr Charles Cartwright

相似试验